Objective: The aim of the study was to develop a model of abdominal sepsis in the experimental animal.
Methods: Sprague-Dawley male rats of 5 weeks (N=39) were used. Initially, a pilot study (N = 9) was performed and distributed in 3 groups with 1cc inoculum of Escherichia coli ATCC 25922 intraperitoneally at concentrations of 10E8, 10E9 and 10E10 CFU. Subsequently, concentrations of 10E10 CFU are used in two groups of 3 rats with dilutions of 10 cc and 15 cc of distilled water respectively. Finally, a randomized trial of 24 rats was started in three treatment groups after intraperitoneal infection: Group I with physiological serum (N = 6), Group II with ceftriaxone (N = 9), Group III with ceftriaxone plus allicin (N = 9). Microbiological samples of blood and peritoneal fluid were made, as well as histopathological study of intraperitoneal organs (liver, diaphragm and peritoneum).
Results: Death of 100% of the rats infected with 10E10 E. coli UFC concentration with the dilution of 15 ml of distilled water and without antibiotic was oberved. The blood culture and peritoneal fluid culture was positive for the same strain in all of them. The formation of abscesses on the liver surface and polymorphonuclear infiltration in tissues were observed.
Conclusions: The lethal dose of E. coli is 10E10 CFU diluted in 15 cc distilled water by intraperitoneal injection.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6987621 | PMC |
| http://dx.doi.org/10.37201/req/064.2019 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Pediococcus acidilactici intake decreases the clinical severity of atopic dermatitis along with increasing mucin production and improving the gut microbiome in Nc/Nga mice.
Biomed Pharmacother
September 2020
Department of Food and Nutrition, Obesity/Diabetes Research Center, Hoseo University, Asan, South Korea. Electronic address:
Article Synopsis
- Atopic dermatitis (AD) is a chronic skin condition linked to gut bacteria, and a study tested the probiotic Pediococcus acidilactici (PA) on both human skin cells and mice to see its effectiveness.
- PA was administered in varying doses over five weeks, and results showed that it improved skin symptoms and reduced markers of inflammation in both models, compared to a control treatment with dexamethasone.
- Additionally, while PA helped maintain gut microbiome balance, the control treatment caused potential liver damage, making PA a more promising option for AD management without severe side effects.
[Development of animal experimental model for bacterial peritonitis].
Rev Esp Quimioter
February 2020
Fco Javier Redondo Calvo, Servicio de Anestesilogía y Reanimación. Unidad de Investigación Traslacional. Hospital General Universitario de Ciudad Real. C/Obispo General Torija s/n.13005. Ciudad Real. Spain.
Objective: The aim of the study was to develop a model of abdominal sepsis in the experimental animal.
Methods: Sprague-Dawley male rats of 5 weeks (N=39) were used. Initially, a pilot study (N = 9) was performed and distributed in 3 groups with 1cc inoculum of Escherichia coli ATCC 25922 intraperitoneally at concentrations of 10E8, 10E9 and 10E10 CFU.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!